October 17, 2016

Specialty medicines made up 36% of all drug spend for the year ended May 2016, according to IMS Health data.

October 11, 2016

Diplomat Pharmacy on Tuesday announced that it is celebrating specialty pharmacists during American Pharmacists Month with a campaign aimed at exploring the role of pharmacists working in specialty. 

October 6, 2016
Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
October 6, 2016

Teva and Celltrion on Thursday announced a new exclusive partnership centered on commercializing two of Celltrion’s biosimilar candidates in the United States and Canada. 

September 28, 2016

Thrifty White recently expanded its capabilities to service specialty patients in all 50 states, and it offers specialty medication pickup at 90 retail locations.

September 27, 2016

BioPlus Specialty Pharmacy announced Tuesday that it had received accreditation from the Accreditation Commission for Health Care (ACHC) with a distinction in oncology. 

September 27, 2016

Walgreens will offer its specialty pharmacists on-demand and live education courses on many of the most prevalent specialty pharmacy-managed disease states, including oncology, fertility, hepatitis C, cystic fibrosis, multiple sclerosis and chronic inflammatory/autoimmune diseases. 

September 26, 2016

Amjevita is the fourth approved biosimilar in the United States, and Amgen’s first approved biosimilar. 

September 26, 2016

Janssen Biotech announced Monday that the Food and Drug Administration had approved its Stelara (ustekinumab) to treat moderately to severely active Crohn’s disease.  

September 26, 2016

Pfizer announced Monday that its board of directors and executive leadership team had decided not to split the company into two separate companies, Pfizer Innovative Health and Pfizer Essential Health. The two will remain separately managed units within Pfizer. 

September 21, 2016

Allergan will be acquiring Akarna Therapeutics and its portfolio of developing treatments for an upfront payment of $50 million plus potential clinical, regulatory and commercial milestone payments around its lead compound AKN-083. 

September 21, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) on Wednesday brought 60 of its member companies’ researchers to Capitol Hill for meetings with members of Congress.

September 20, 2016

Allergan has announced an acquisition aimed at making it a leader in the development of treatment for nonalcoholic steatohepatitis (NASH), a disease state seeing increased interest from drug makers. 

September 20, 2016
BioPharmaDIVE is reporting on a recently filed lawsuit from Sanofi contending that Merck & Co. infringed on its patents for Lantus (uinsulin glargine) and its insulin delivery device soloSTAR. The lawsuit follows Merck’s announcement that it had filed a New Drug Application with the Food and Drug Administration for follow-on biologic insulin glargine product. It has previously sued Eli Lilly & Co., alleging that its insulin biosimilar infringed on its patents, which delayed the launch of Lilly’s Basalgar until December. (BioPharmaDIVE)
 

 

September 19, 2016

Both the Pharmaceutical Research and Manufacturers of America and the Biotechnology Innovation Organization issues statements in support of the letter.

September 13, 2016
The partnership between KloudScript and Illinois independent Doc’s Pharmacy allows for patient access to specialty pharmacy treatments at retail as an alternative to mail-order specialty pharmacies. 
 
September 12, 2016

“We are excited to welcome Excelera members into NASP and important conversations around appropriate access to specialty medications and related services,” NASP membership committee chair Mike Agostino said

September 12, 2016

According to the report, some 311 medicines and vaccines for autoimmune diseases are either in clinical trials or awaiting Food and Drug Administration approval. 

September 8, 2016

"We think Kroger is going to be a winner in the health and wellness market, and we are excited to see what they build from this point forward," commented Casey Lynch, Altamont managing director.

September 7, 2016

The company is encouraging people to share their stories about experiences with cancer — either their personal experience or that of someone they know — using the hashtag #CancerTaughtMe. 

September 7, 2016

Pharmacy technology company ScriptPro is positioning itself as a provider of solutions that will ease common pain points that come with increased script volume and the influx of paperwork from clinical services with two forthcoming innovations that address pharmacy documentation needs and the will-call process.

September 6, 2016

The acquisition saw Allergan pay RetroSense Therapeutics a $60 million upfront payment, with the promise of potential regulatory and commercialization milestone payments for the company’s lead development program, RST-001 — a potential therapy for retinitis pigmentosa. 

August 30, 2016

Two recent unanimous approval recommendations from FDA advisory committees regarding biosimilars is a signal of growing scientific acceptance and understanding of the biosimilar regulatory pathway, suggested The National Law Review in a report Tuesday. The National Law Review has created a chart summarizing pending and approved BLAs for biosimilars using publicly available information, the publication noted, but there are still two barriers to entry. As biosimilars gain FDA approval, patent issues remain a barrier and the exorbitant R&D cost prevent significant price disparities. Accordingly, insurers may be slow to add biosimilars to the formulary, The National Law Review suggested. (The National Law Review)

August 22, 2016

The app allows hemophilia patients to record bleeding episodes and treatment while facilitating easy information sharing with their caregivers, physicians, pharmacists and nurses.